FDA Inspection 878683 — New York Presbyterian Hospital Weill Cornell Medical College
The FDA completed an inspection of New York Presbyterian Hospital Weill Cornell Medical College on May 14, 2014 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 14, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- New York, NY (United States)